Atrial fibrillation is one of the conditions I encounter most frequently in clinical practice, and one that I find genuinely important to explain well. The gap between what patients understand about it and what they need to understand can have real consequences.

Many people are told they have AF and walk away with a vague impression of an “irregular heartbeat” without fully grasping why their doctor is so focused on stroke prevention, sometimes even in the absence of any symptoms at all.

This article is an attempt to bridge that gap. AF is common, it is well understood, and, with the right management, it is very manageable. Understanding why treatment matters, particularly anticoagulation, is essential to taking an active role in your own care.

What Is Atrial Fibrillation?

The heart has its own built-in electrical system that coordinates every heartbeat. Normally, a signal originates from a cluster of cells called the sinus node located in the right atrium, and travels in an orderly sequence through the upper chambers (the atria) and then down to the lower chambers (the ventricles), causing them to contract and pump blood. This produces a regular, coordinated heartbeat.

In atrial fibrillation, this orderly process breaks down. Instead of a single organised signal from the sinus node, chaotic electrical impulses fire simultaneously from multiple sites around the atria. The atria quiver rather than contract properly, and the ventricles receive a barrage of irregular signals, causing the heart to beat in a completely unpredictable pattern.

This is what produces the characteristic pulse of AF: irregularly irregular with no discernible pattern to the spacing between beats.

When I examine a patient’s pulse and feel that characteristic irregular rhythm, sometimes fast, sometimes slower, but never regular, AF is immediately high on the list. An ECG confirms the diagnosis within seconds, showing the absence of organised atrial activity and the irregular ventricular response.

When you feel the pulse in someone with AF, there is no pattern to it at all, not just fast, not just slow, but completely unpredictable from beat to beat. That irregularity is the hallmark of the condition and immediately recognisable to any clinician who has examined a few patients with it.

Types of Atrial Fibrillation

Paroxysmal AF comes and goes, with episodes that start and stop on their own, typically lasting from minutes to a few days. Persistent AF lasts longer than seven days and does not resolve without treatment.

Long-standing persistent AF has been continuously present for more than a year. Permanent AF is AF that has been accepted as the ongoing rhythm, a decision made jointly by the patient and their treating team when efforts to restore a normal rhythm are no longer being pursued.

Understanding which type you have matters because it shapes the treatment strategy, whether the goal is to restore and maintain a normal rhythm, or to manage the rate of the irregular rhythm and focus on stroke prevention.

Symptoms, and Why Many People Have None

The symptoms of AF can vary considerably from person to person. Some people are acutely aware of every episode, experiencing palpitations, a racing or fluttering sensation in the chest, fatigue, breathlessness, or dizziness. Others feel virtually nothing.

It is genuinely common to diagnose AF incidentally, during a routine pulse check, a pre-operative assessment, or an ECG performed for an unrelated reason, in someone who had no idea anything was wrong.

This variability is one of the reasons AF is so important to understand. The absence of symptoms does not mean the condition is benign or that treatment is not needed. The stroke risk associated with AF exists regardless of whether the AF is producing symptoms.

What Causes Atrial Fibrillation?

AF arises from a combination of structural and electrical changes in the heart, often in the context of underlying conditions or lifestyle factors that place additional demand on the atria. Age is the single most important risk factor, the prevalence of AF rises significantly with each decade of life.

High blood pressure is the most common modifiable contributor. Chronically elevated pressure causes the atrial walls to thicken and stretch over time, creating the conditions for chaotic electrical activity. Heart failure, coronary artery disease, and valve disease particularly mitral valve disease, all alter the structure of the atria and increase AF risk.

Obstructive sleep apnoea is an underappreciated but well-established contributor. Repeated overnight oxygen drops place significant stress on the atria, and treating sleep apnoea effectively with CPAP can meaningfully reduce AF burden.

Alcohol has a particularly direct relationship with AF. Even moderate intake can trigger episodes in susceptible individuals, and heavy use is a well-recognised acute precipitant. Obesity, diabetes, and thyroid disorders particularly an overactive thyroid, are also relevant contributing factors.

It is worth saying clearly, however: AF does not only affect people with significant underlying disease. A meaningful proportion of cases occur in people who are otherwise healthy, fit, and well, including endurance athletes and people who exercise regularly and intensively.

In highly trained individuals, years of sustained endurance activity can cause gradual structural changes to the heart, including enlargement of the atria, that create a substrate for AF. This is sometimes called “athlete’s heart” or lone AF in fit individuals. It does not mean sport or exercise is harmful, and it certainly should not be a source of alarm. AF in this context is very manageable.

Similarly, in some people AF appears without any identifiable cause. Identifying the cause where one exists is always worthwhile, because treating contributing factors, particularly blood pressure and sleep apnoea, directly improves AF management. But the absence of a clear cause is not unusual and is not a reason for additional alarm.

Why AF Raises the Risk of Stroke

This is the part of the AF story that I find most important to explain clearly, because it is the reason why treatment, particularly anticoagulation, matters so much even when someone feels completely well.

When the atria fibrillate rather than contract in a coordinated way, blood does not move through them as efficiently. In particular, a small pouch called the left atrial appendage a finger-like structure attached to the left atrium, tends to become a site of sluggish blood flow. When blood pools and moves slowly, it has a tendency to clot.

A clot that forms in the left atrial appendage can break away at any time, travel through the circulation, and lodge in an artery supplying the brain. The result is an ischaemic stroke, and strokes caused by AF tend to be particularly severe, because the clots involved are often larger than those from other causes.

This mechanism explains why AF-related stroke prevention is not about the symptoms of AF, but about the underlying condition itself. A person can be in AF without knowing it, feel perfectly well, and still be at meaningfully elevated stroke risk.

Assessing Stroke Risk, The CHA₂DS₂-VASc Score

Not everyone with AF has the same stroke risk, it varies considerably depending on individual factors. To guide decisions about anticoagulation, clinicians use a validated scoring tool called the CHA₂DS₂-VASc score. Each letter represents a clinical factor that independently raises stroke risk in AF, with points assigned accordingly.

A score of 0 in a male patient is generally considered low risk, and anticoagulation may not be required. A score of 1 represents intermediate risk, a conversation worth having carefully with your doctor.

A score of 2 or above indicates elevated risk, and anticoagulation is generally recommended. The decision always involves weighing stroke prevention benefit against individual bleeding risk, it is never one-size-fits-all.

The CHA₂DS₂-VASc score is a starting point for a conversation, not a verdict. It helps clinicians and patients think through individual risk in a structured way, and the treatment decision is always made together.

Treatment Options for AF

AF management has several components, stroke prevention, control of the heart rate or rhythm, and treatment of contributing causes. No single approach suits everyone, and the right strategy depends on the type of AF, your symptoms, your heart’s structure and function, and your individual circumstances.

Watch, Monitor and Lifestyle

For some people, particularly those with very infrequent, brief, and minimally symptomatic paroxysmal AF and a low CHA₂DS₂-VASc score, careful monitoring with lifestyle optimisation may be the initial approach.

This means addressing contributing factors directly: reducing alcohol, losing weight if relevant, treating sleep apnoea, and managing blood pressure well. These changes alone can reduce AF burden significantly in the right patient.

Anticoagulation, Stroke Prevention

For most people with AF and a meaningful stroke risk, anticoagulation is the most important treatment. Direct Oral Anticoagulants (DOACs) apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), and edoxaban, are now the preferred choice for most patients, offering predictable dosing without regular blood test monitoring.

Warfarin remains an option where DOACs are not suitable. Taking anticoagulation consistently is one of the most impactful things a person with AF can do for their long-term health.

Rate Control

Rate control accepts AF as the ongoing rhythm but uses medication to keep the ventricular rate within a comfortable range, typically below 100 beats per minute at rest.

Common rate control medications include beta-blockers (such as metoprolol or bisoprolol), calcium channel blockers (diltiazem or verapamil), and digoxin. This approach suits many patients, particularly those with long-standing or permanent AF, older patients, or those in whom rhythm control is not the priority.

Rhythm Control, Medications

Rhythm control aims to restore and maintain normal sinus rhythm. Antiarrhythmic medications used for this purpose include flecainide (for people with structurally normal hearts, also used as a “pill in the pocket” for paroxysmal AF), sotalol and amiodarone.

Each has specific indications, monitoring requirements, and side effects, the right choice depends on your individual cardiac history and function.

Cardioversion

Cardioversion is a procedure that restores sinus rhythm using a carefully controlled electrical shock delivered to the chest under brief sedation. It is typically performed after adequate anticoagulation has been established.

Cardioversion is effective at resetting the rhythm but does not prevent AF from recurring, it is often combined with antiarrhythmic medication or ablation to maintain the result.

Catheter Ablation, Pulmonary Vein Isolation (PVI)

Catheter ablation targets the electrical triggers of AF, most commonly firing from the pulmonary veins where they connect to the left atrium, and electrically isolates them. Pulmonary vein isolation (PVI) is now a well-established and effective rhythm control strategy, particularly for paroxysmal AF.

It is performed via catheters introduced through the veins, without open-heart surgery. Success rates are good, and many patients achieve freedom from AF episodes or significant reduction in their burden. Repeat procedures are sometimes needed.

Pulse Field Ablation (PFA)

PFA is one of the most significant recent advances in AF ablation. Unlike thermal ablation techniques, which use heat or cold energy and carry a small risk of injury to surrounding structures including the oesophagus, PFA uses precisely targeted electrical pulses that selectively affect cardiac tissue while largely sparing adjacent structures.

Early clinical experience shows excellent efficacy, a favourable safety profile, and shorter procedure times, making it an increasingly preferred approach at experienced centres.

Surgical Ablation

For patients who are already undergoing open-heart surgery for another reason, such as valve repair or replacement, or coronary bypass surgery, AF ablation can often be performed at the same time.

The surgeon creates lesion lines in the atrial tissue to interrupt the electrical circuits that sustain AF. This combined approach avoids the need for a separate ablation procedure and can be highly effective in appropriately selected patients.

AV Node Ablation and Permanent Pacemaker

In patients where AF cannot be controlled with medication and other approaches, and symptoms remain significantly limiting, AV node ablation with permanent pacemaker implantation is an option.

The procedure deliberately interrupts the electrical connection between the atria and ventricles, stopping the chaotic atrial signals from reaching the ventricles, and a pacemaker then drives a regular, controlled heart rate. It does not cure AF, but it can dramatically improve quality of life and symptoms.

Anticoagulation is still required after this procedure. It is typically considered when other strategies have been exhausted or are not suitable.

The Role of the Echocardiogram in Guiding Treatment

One of the first investigations in any AF assessment is an echocardiogram, a cardiac ultrasound that provides important information beyond simply confirming AF. The size of the left atrium and left ventricular function both directly influence treatment decisions.

A significantly enlarged left atrium suggests more advanced atrial remodelling over time. In these patients the likelihood of successfully restoring and maintaining sinus rhythm is lower, shifting the focus toward rate control and anticoagulation.

A mildly enlarged or normal-sized left atrium suggests the rhythm is more likely to respond well to cardioversion or ablation. This is one of many reasons why a thorough assessment at diagnosis shapes the entire management strategy.

Conclusion

Atrial fibrillation is one of the most common conditions I manage, and one where patient understanding genuinely changes outcomes. The central message is this: AF raises stroke risk through a mechanism that operates silently, independent of whether you feel the AF or not.

That is why anticoagulation matters even when someone feels perfectly well, and why it is worth having a careful conversation with your doctor about your individual CHA₂DS₂-VASc score and what it means for your treatment.

AF does not require a diseased or failing heart to develop, it can occur in fit, active, otherwise healthy people. A diagnosis of AF is not a reflection of your overall cardiovascular health, and it is not a reason for alarm. What it is, is a reason to engage, with treatment, with lifestyle, and with your medical team.

The options available today are genuinely good, and most people with AF live full, active, and confident lives.

More from Heart Matters

• Treatment Strategies for Atrial Fibrillation (AF)
• Understanding the Difference Between Warfarin and DOACs
• Flecainide: A Rhythm Control Medicine for AF and SVT
• Sotalol: An Antiarrhythmic Medicine for AF and Ventricular Arrhythmias
• Transient Ischaemic Attack (TIA): Understanding the Warning and Taking Action
• Free Resources, Risk Factor Checklist and More